Home > Balance Sheet > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹5,218 Cr₹4,247 Cr₹6,172 Cr₹5,270 Cr₹4,611 Cr

What is the latest Net Current Assets ratio of GLAND PHARMA ?

The latest Net Current Assets ratio of GLAND PHARMA is ₹5,218 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹5,218 Cr
Mar2024₹4,247 Cr
Mar2023₹6,172 Cr
Mar2022₹5,270 Cr
Mar2021₹4,611 Cr

How is Net Current Assets of GLAND PHARMA Trending?

Years Net Current Assets % Change
Mar2025 ₹5,218 Cr
22.87
Mar2024 ₹4,247 Cr
-31.19
Mar2023 ₹6,172 Cr
17.11
Mar2022 ₹5,270 Cr
14.29
Mar2021 ₹4,611 Cr -

Compare Net Current Assets of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹33,253.3 Cr 1.5% 3% 11.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,368.0 Cr 0.7% -0.7% -11% Stock Analytics
DIVIS LABORATORIES ₹160,631.0 Cr NA -1.6% 12.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,641.0 Cr 3.1% -0.9% 9.1% Stock Analytics
CIPLA ₹123,419.0 Cr -2% -4% -5.9% Stock Analytics
DR REDDYS LABORATORIES ₹109,176.0 Cr -0.2% 2.4% 0% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

1.5%

3%

11.5%

SENSEX

-0.3%

0.1%

-1%


You may also like the below Video Courses